trending Market Intelligence /marketintelligence/en/news-insights/trending/6qqpu9d8mmpjmekfrmc5ja2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Leap Therapeutics raises $16.1M via common stock offering

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Leap Therapeutics raises $16.1M via common stock offering

Leap Therapeutics Inc. raised $16.1 million in gross proceeds from the sale of 2,146,667 common shares in an underwritten public offering.

The shares sold included 280,000 shares sold pursuant to the full exercise of the underwriters' option to buy additional shares.

Raymond James & Associates Inc. and Ladenburg Thalmann acted as book-running managers for the offering.